MOTREM

Nangibotide · Inotrem

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MOTREM, covering 2024-10-08 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of 3 Doses of MOTREM (Nangibotide) in Patients With Septic Shock [Phase 2]

See pricing